Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2002
10/17/2002WO2002080955A1 Stimulation of osteogenesis using rank ligand fusion proteins
10/17/2002WO2002080954A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002WO2002080952A2 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways
10/17/2002WO2002080888A2 Estrogen receptor-related receptor alpha (err) agonist for inducing cartilage formation
10/17/2002WO2002080847A2 Use of tumor necrosis factor inhibitors to treat cardiovascular disease
10/17/2002WO2002080845A2 Novel eps8 compounds for therapy and diagnosis and methods for using same
10/17/2002WO2002080844A2 Novel bgp compounds for therapy and diagnosis and methods for using same
10/17/2002WO2002080842A2 Medicament and method for diagnosing an autoimmune condition_in particular psoriasis
10/17/2002WO2002080763A2 Blood testing device
10/17/2002WO2002080758A2 Methods for treating drug addiction
10/17/2002WO2002080663A1 Experimental animals for evaluation of therapeutic effects on corneal epithelial damages
10/17/2002WO2002080647A2 Methods and reagents for multiplexed analyte capture, surface array self-assembly, and analysis of complex biological samples
10/17/2002WO2002066990A3 Immobilised cardiolipin probes
10/17/2002WO2002063036A3 Vector system used in screening active substances
10/17/2002WO2002060924A3 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
10/17/2002WO2002059619A3 Method for the diagnosis of alzheimer's disease
10/17/2002WO2002059585A3 Oxygen monitoring apparatus and methods of using the apparatus
10/17/2002WO2002059140A3 Ikaros rgulatory elements and uses thereof
10/17/2002WO2002057740A3 Use of targeted glycemic profiles in the calibration of a noninvasive blood glucose monitor
10/17/2002WO2002048702A3 Material sensor with protective layer
10/17/2002WO2002044725A8 Bioanalytical assay
10/17/2002WO2002044205A3 Peptides from ag85 of mycobacterium and uses thereof
10/17/2002WO2002042778A3 For amyloid formation inhibitors
10/17/2002WO2002040700A3 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
10/17/2002WO2002038607A3 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
10/17/2002WO2002037120A3 Diagnosis of pre-eclampsia
10/17/2002WO2002036804A3 Method for detecting hematopoietic stem cells
10/17/2002WO2002036733A9 Cd36 as a heat shock protein receptor and uses thereof
10/17/2002WO2002030265A3 Method and display for multivariate classification
10/17/2002WO2002029061A3 G-protein coupled receptors
10/17/2002WO2002023195A3 Method for detecting clostridium botulinum neurotoxin serotypes a, b, e and f in a sample
10/17/2002WO2002022869A3 Directed evolution method
10/17/2002WO2002021130A3 Method and device for simultaneous detection of multiple components in a mixture
10/17/2002WO2002016555A3 Htert-immortalised cell lines, their preparation and use
10/17/2002WO2002016417A3 Transgenic animal model for neurodegerative disease and uses thereof
10/17/2002WO2002015920A3 Treatment of hyperproliferative diseases
10/17/2002WO2002012854A9 Systems and methods for providing information concerning chromophores in physiological media
10/17/2002WO2002010752A3 Sensor chips with multi-layers of polysiloxane
10/17/2002WO2002006806A3 Antioxidant sensor
10/17/2002WO2002004669A3 Improved capture and detection format versatility for dipstick assays
10/17/2002WO2002004489A9 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/17/2002WO2002000920A3 Ingestibles possessing intrinsic color change
10/17/2002WO2001098354A3 Human receptors
10/17/2002WO2001098323A3 G-protein coupled receptors
10/17/2002WO2001094527A3 Preparing a sample to be analysed from a sample with very large volume
10/17/2002WO2001077378A3 Diagnosis of diseases associated with dna adducts
10/17/2002WO2001063241A3 Microfluidic devices and methods
10/17/2002WO2001061053A9 Protein and peptide sensors using electrical detection methods
10/17/2002WO2001061031A9 Improved assay for protein tyrosine phosphatases
10/17/2002WO2001059683A9 Integrated genomic services
10/17/2002WO2001058958A9 Antibody binding superficial zone protein and their uses in diagnosis and screening methods
10/17/2002WO2001055444A9 Method for the evaluation of implantable materials
10/17/2002WO2001055170A9 Mob-5/hmob-5 as a cancer diagnostic marker
10/17/2002WO2001054723A9 Therapeutic method for reducing angiogenesis
10/17/2002WO2001054712A9 Compositions and methods for the early diagnosis of ovarian cancer
10/17/2002WO2001054552A9 Disposable surface wipe article having a waste contamination sensor
10/17/2002WO2001040497A3 Method for obtaining nucleic acids from an environment sample
10/17/2002WO2000002044A3 Engine oil test method
10/17/2002US20020152499 Gene encoding a protein involved in the signal transduction cascade leading to systemic acquired resistance in plants
10/17/2002US20020152485 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/17/2002US20020152481 Genetic engineering; qualitative analysis
10/17/2002US20020152480 Alpha-synuclein super-mutants accelerate alpha-synuclein aggregation
10/17/2002US20020152479 Car modulators: screening and treatment of hypercholesterolemia
10/17/2002US20020152196 cDNA database and biochip for analysis of hematopoietic tissue
10/17/2002US20020152037 Multiple sensing system and device
10/17/2002US20020152036 System for optimized control of multiple oxidizer feedstreams
10/17/2002US20020152009 Method and apparatus for determining operational air quality and predicting vehicle performance
10/17/2002US20020151814 Detection of conditions by analysis of gases or vapours
10/17/2002US20020151706 Antiinflammatory agents
10/17/2002US20020151695 Transforming growth factor-beta-related molecules and uses thereof
10/17/2002US20020151688 Generating virally deactivated immunoglobulin; obtain mixture containing immunoglobulin, suspend in carbohydrate solution, reduce impurities, apply column, filter, recover efluent, inactivate with virus, preciptate and recover immunoglobulin
10/17/2002US20020151684 Fusion protein and uses thereof
10/17/2002US20020151680 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/17/2002US20020151678 Prophylaxis and therapy of acquired immunodeficiency syndrome
10/17/2002US20020151677 Replikins and methods of identifying replikin-containing sequences
10/17/2002US20020151646 Comprises glutamic acid, sodium glutamate, or glycine; for measurement of coagulation factor; sensitivity; blood screening; freeze-drying
10/17/2002US20020151588 Dissociated glucocorticoid receptor antagonists for the treatment of glucocorticoid associated side effects
10/17/2002US20020151583 Prevention of liver cancer by administration of simvastatin
10/17/2002US20020151569 Peroxisome Proliferator Activated Receptors (PPARs) antagonists 4-oxo-5-thiazolidine acetamide derivatives
10/17/2002US20020151542 Method for determining whether a compound is an insulin receptor kinase activator
10/17/2002US20020151505 Treatment of helicobacter with isothiocyanates
10/17/2002US20020151498 Medicaments that modify activity of Lipolysis Stimulated Receptor and that can be used to influence partitioning of dietary lipids between liver and peripheral tissues, including adipose tissue
10/17/2002US20020151494 Novel amino acid sequences for human semaphorin-like polypeptides
10/17/2002US20020151489 Promoting the growth of new lymph vessels (lymphangiogenesis) by administering a vascular endothelian factor (VEGF), e,g, VEGF-2; treating lymphedema and related disorders; screening comounds capable of inducing new lymph vessel growth.
10/17/2002US20020151487 Method and reagents for epithelial barrier formation and treatment of malignant and benign skin disorders by modulating the notch pathway
10/17/2002US20020151484 SID nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof
10/17/2002US20020151480 Identifying a compound to treat a cardiovascular disease, e.g., atherosclerosis, characterized by aberrant 10218 nucleic acid activity or expression; detecting the presence of a nucleic acid in the sample that hybridizes to the probe
10/17/2002US20020151479 Nucleic acids, proteins, and antibodies
10/17/2002US20020151475 Compounds and methods for modulating cell adhesion
10/17/2002US20020151470 Inhibitors of phospholipase A2
10/17/2002US20020151464 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
10/17/2002US20020151457 FRA -1 expression in brain cancer
10/17/2002US20020151088 Rapamycin conjugates
10/17/2002US20020151087 Determine the concentration of preferential analyte in sample; obtain sample, apply to immunoaffinity column, separate particles, determine preefrential particle concentration by chromatographic immunoassay
10/17/2002US20020151086 Analysis of free analyte fractions by rapid affinity chromatography
10/17/2002US20020151083 Preparing crude oils for use as source of asphalt; obtain crude oil sample, perform spectrum analysis, classify crude oil and suitability for use in asphalt
10/17/2002US20020151081 Biosensors for the qualitative and/or quantitative determination of organometallic compounds in sample
10/17/2002US20020151077 Apparatus for use in the generation of microarray for use in the detection of prefeentialparticles in sample
10/17/2002US20020151075 Food freshness indicator
10/17/2002US20020151074 Compound for use in clearing particulate matter from sample